The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.15
Bid: 8.80
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.70 (7.955%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.15
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMilller Chairman sells over 11m pounds in shares

Tue, 23rd Jul 2013 16:21

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of shares in the company.Mackay sold a total of 350,000 shares between July 16-18th through three separate transactions, the firm revealed on Tuesday. He sold: 138,000 at 3,266.8p each; 50,000 at 3,250.74p each; and another 162,000 at 3,251.4p each.He pocketed £11.4m through the sale, leaving his holding at just over 1.4m shares.The director first joined the beverages company back in 1978 when it was known as South African Breweries and was its Chief Executive Officer (CEO) at the time of its listing in London in 1999. The company was renamed to SABMiller following the purchase of US group Miller Brewing Company in 2002.Mackay was appointed Executive Chairman in July 2012 but, after being diagnosed with a brain tumour in April, the firm accelerated the promotion of Alan Clark to CEO with Mackay taking a more back-seat position of Non-Executive Chairman. At the time of Clark's appointment, the company said it would keep Mackay's position under review until the outcome of his treatment following surgery in April.SABMiller's share price has increased by nearly 16% since the start of 2013.Top Director BuysVerona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 3,000,000 @ 1.67p Value: £50,100Scancell Holdings (SCLP) Director name: Ms Katherine Cornish-BowdenAmount purchased: 45,000 @ 32.00p Value: £14,400Top Director SellsSABMiller (SAB) Director name: Mr Graham MackayAmount sold: 162,000 @ 3,251.40p Value: £5,267,268SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 138,000 @ 3,266.80p Value: £4,508,184SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 50,000 @ 3,250.74p Value: £1,625,370Accsys Technologies (AXS) Director name: Mr Paul Hugh Anthony Clegg Amount sold: 1,500,000 @ € 0.14 Value: € 204,000Accsys Technologies (AXS) Director name: Mr Hans Pauli Amount sold: 330,000 @ € 0.14 Value: € 44,880Accsys Technologies (AXS) Director name: Mr William Bickerton RudgeAmount sold: 119,686 @ € 0.14 Value: € 16,277BC
More News
22 Oct 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Oct 2021 20:41

IN BRIEF: Scancell bases new facility at Oxford Science Park

IN BRIEF: Scancell bases new facility at Oxford Science Park

Read more
5 Oct 2021 22:03

IN BRIEF: Scancell doses first subject in Covidity phase one trial

IN BRIEF: Scancell doses first subject in Covidity phase one trial

Read more
26 Aug 2021 12:53

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

TRADING UPDATES: Caerus, Bezant pick Cyprus asset; TomCo buys JV

Read more
26 Aug 2021 12:38

Scancell gets MHRA approval for Modi-1 clinical trial

(Sharecast News) - Immunotherapy developer Scancell announced on Thursday that the UK Medicines and Healthcare products Regulatory Authority (MHRA) has approved the clinical trial application to initiate the first-in-human phase 1 and 2 clinical study of 'Modi-1'.

Read more
17 Aug 2021 15:32

Scancell chooses needle-free tech for Covid vaccine candidates

(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell has selected the PharmaJet needle-free injection system to administer its two SARS-CoV-2 vaccine candidates for Covid-19, 'SCOV1' and 'SCOV2', in its 'COVIDITY' phase 1 clinical trial, it announced on Tuesday.

Read more
30 Jul 2021 14:24

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

DIRECTOR DEALINGS: Harbour Energy CEO for Europe buys 100,000 shares

Read more
29 Jul 2021 22:08

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

TRADING UPDATES: Salt Lake funding talks; Resolute cuts output outlook

Read more
28 Jul 2021 22:00

IN BRIEF: Scancell turns once again to Durrant to lead company

IN BRIEF: Scancell turns once again to Durrant to lead company

Read more
22 Jun 2021 15:21

Scancell makes progress with 'Covidity' trial plans

(Sharecast News) - Immunotherapy developer Scancell updated the market on 'Covidity' clinical trial plans, and the publication of preclinical data on two vaccine candidates from the research programme.

Read more
22 Jun 2021 12:14

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

IN BRIEF: Scancell plans new Covid vaccine trial in South Africa, UK

Read more
7 Jun 2021 13:58

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys more shares

Read more
7 Jun 2021 10:38

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

AIM WINNERS & LOSERS: NetScientific surges on Astra Covid test pact

Read more
30 Apr 2021 14:30

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

IN BRIEF: Scancell Non-Exec Director Martin Diggle buys 400,000 shares

Read more
19 Feb 2021 20:13

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

IN BRIEF: Associate Of Scancell Director Sells GBP109,000 In Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.